Dinesh Vinoobhai Patel

This inventor holds 60 USPTO granted patents and 10 published patent applications, plus 3 CIPO patents and 5 EPO patents, primarily in Peptide Inhibitors (CPC class C07K). Top assignees: Protagonist Therapeutics, Inc., Pharmacia & Upjohn Company, Affymax Technologies, N.v.. Active years: 1989-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dinesh Vinoobhai Patel. Retrieved from https://idiyas.com/inventor/dinesh-vinoobhai-patel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 60 (Patent Applications = 10)

% Patents Active = 71.7

CIPO Patents = 3 (Patent Applications = 6)

EPO Patents = 5 (Patent Applications = 11)

Average Co-Inventor Count = 3.5

ph-index = 18

Forward Citations = 823(Granted Patents)

Forward Citations (Not Self Cited) = 660(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Somerset, NJ (US) (1989 - 1993)
Freemont, CA (US) (2002 - 2004)
Fremont, CA (US) (1996 - 2024)

Company Filing History:

17 out of 35

Protagonist Therapeutics, Inc.

patents

13 out of 523

Pharmacia & Upjohn Company

patents

6 out of 88

Affymax Technologies, N.v.

patents

4. 6 out of 23

Vicuron Pharmaceuticals Inc.

Miikana Therapeutics, Inc.

patents

7. 2 out of 1,624

E. R. Squibb Sons, Inc.

Bristol Meyers Squibb Company

patents

10. 1 out of 3,745

Bristol-Myers Squibb Compnay

Protaganist Therapeutics, Inc.

patent

13. 1 out of 834,601

Other

patents

Years Active: 1989-2026

Loading Chart...

Areas of Expertise:

Peptide Inhibitors

Interleukin-23 Receptor

Inflammatory Bowel Diseases

Antimicrobial Compounds

Dimer Antagonists

Integrin Antagonists

Cyclic Peptides

Kinase Inhibitors

Histone Deacetylase Inhibitors

Oxazolidinone Libraries

Antibacterial Activity

Quinolone Derivatives

60 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12673974 - Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases (2026-07-07),

2. 11884748 - Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases (2024-01-30),

3. 11840581 - α4β7 thioether peptide dimer antagonists (2023-12-12),

4. 11111272 - α4α7 peptide monomer and dimer antagonists (2021-09-07),

5. 10941183 - Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases (2021-03-09),

6. 10787490 - Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases (2020-09-29),

7. 10626146 - α4β7 thioether peptide dimer antagonists (2020-04-21),

8. 10407468 - Methods for synthesizing α4β7 peptide antagonists (2019-09-10),

9. 10301371 - Cyclic monomer and dimer peptides having integrin antagonist activity (2019-05-28),

10. 10196424 - Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases (2019-02-05),

11. 10059744 - α4β7 thioether peptide dimer antagonists (2018-08-28),

12. 10035824 - Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases (2018-07-31),

13. 10023614 - Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases (2018-07-17),

14. 9809623 - α4β7 peptide monomer and dimer antagonists (2017-11-07),

15. 9714270 - a4B7 integrin thioether peptide antagonists (2017-07-25),

Title: Dinesh Vinoobhai Patel: Innovator in Peptide Therapeutics

Introduction

Dinesh Vinoobhai Patel, a prominent inventor based in Fremont, CA, has made significant contributions to the field of peptide therapeutics. With an impressive portfolio of 56 patents, Patel's work primarily focuses on developing innovative peptide compounds that target specific biological pathways.

Latest Patents

Patel's latest patents include groundbreaking inventions such as "α4β7 thioether peptide dimer antagonists.” This invention describes thioether monomer and dimer peptide molecules that inhibit the binding of α4β7 to the mucosal addressing cell adhesion molecule (MAdCAM) in vivo. Another notable patent is the "α4α7 peptide monomer and dimer antagonists." This invention relates to peptide dimer and monomer compounds that effectively block the binding of α4β7 to MAdCAM, showcasing high selectivity against α4β1 binding and remarkable stability under gastrointestinal conditions.

Career Highlights

Throughout his career, Patel has worked with esteemed organizations such as Protagonist Therapeutics, Inc. and Pharmacia & Upjohn Company. His experience in these companies has allowed him to hone his skills and innovate in the field of biochemistry and pharmacology, particularly relating to peptide therapeutics.

Collaborations

Dinesh Patel has collaborated with talented professionals in his field, including Ashok Bhandari and Mikhail Fedorovich Gordeev. These collaborations have contributed to the development and refinement of several of his patented inventions.

Conclusion

Dinesh Vinoobhai Patel's innovative contributions to the field of peptide therapeutics underscore his status as a leading inventor. His extensive patent portfolio reflects his dedication to advancing medical science and improving therapeutic outcomes. As he continues to push the boundaries of innovation, Patel remains an influential figure in his field.

Profile summary based on public USPTO records.